The Food and Drug Administration is ramping up technology adoption, and prioritizing AI and data strategies to ensure safety of new interventions and medical devices, improve workflows and ultimately deliver on its public health mission. Arunan Skandarajah, an FDA Presidential Innovation Fellow who believes in the power of equitable digital tools, discusses how he is innovating FDA’s regulatory processes to drive greater efficiencies.
HealthCast
Season 2
Episode 30
36m listen
How AI, Data Are Boosting FDA’s Regulatory Processes
Share
A Presidential Innovation Fellow is helping the agency improve workflows and ultimately ensure safety of the drugs and treatments it regulates.
-
Arunan Skandarajah Presidential Innovation Fellow FDA
Related Content
-
What Battery Recycling Could Tell Us About AI's Role in Experimentation
A Genesis Mission project tests how AI agents can reduce physical experiments and accelerate critical mineral recovery from used batteries.
4m read -
AI Summit
The 2027 AI Summit convenes government and industry leaders to examine the next generation of artificial intelligence shaping federal missions.
Washington, D.C. -
Federal Cloud & Data Forum
The 2027 Cloud & Data Forum brings together federal technology, data and industry leaders to explore how modern infrastructure and trusted data are enabling more agile, intelligent government operations.
Washington, D.C. -
Federal AI Forum
The 2027 AI Forum brings together federal AI leaders, practitioners and industry experts to examine how artificial intelligence is being applied to real-world government missions.
Reston, VA
